Blue Stream Laboratories, an analytical laboratory specializing in recombinant glycoprotein and complex biologics characterization services, is expanding its antibody-drug conjugates (ADC) capabilities. ADCs are a growing class of drugs that use high-targeting antibodies to deliver potent anti-cancer drugs. ADCs can target and deliver higher doses to specific tumor markers, while eliminating side effects common with chemotherapy.   “The ADC field is expanding and, thus, generating a lot of int...